Developer docs
API playgroundTry for free, no card

Search company profiles

Epilepsy Society

Full company profile

uuid000v7t5

Namestring
Epilepsy Society
Legal namestring
Epilepsy Society
Company typeenum
Private
Founded yearint
1892
Descriptiontext

Epilepsy Society is a UK registered charity (Charity No. 206186) founded in 1892 and headquartered at the Chalfont Centre in Chalfont St Peter, Buckinghamshire, with a workforce of 251–500 staff. It operates across four functional pillars: specialist medical services (MRI scanning, EEG recording including video telemetry, sleep-deprived EEG, ambulatory EEG, and Therapeutic Drug Monitoring), a research programme spanning genomics, neuroimaging, neuropathology, and neuropsychology — including the UK's only specialist epilepsy genomics clinic running whole genome sequencing — care services (residential care homes, STEPS supported living, overnight respite), and an advocacy and information function delivered via a confidential helpline, training programmes for families and professionals, and a global-facing website (epilepsysociety.org.uk). The proprietary EASEE device (Epicranial Application of Stimulation Electrodes for Epilepsy) is offered on the NHS for people with drug-resistant focal seizures.

The organisation funds its operations through a diversified income mix including individual donations, legacies and gifts in Wills, membership fees, fundraising events (walks, treks, runs, skydiving, overseas challenges), corporate partnerships, and shop proceeds; services are delivered free at the point of use consistent with its charitable mission. It serves a UK population of more than 600,000 people with epilepsy and addresses a clinical burden of 79 new diagnoses per day and roughly 1,200 epilepsy-related deaths per year. Customer-facing segments include people with epilepsy (and subgroups such as children, women, and those with learning disabilities), families and carers, healthcare professionals, and people requiring residential or supported living care. The organisation is governed by a Board of Trustees with Clare Pelham as Chief Executive, and there are no subsidiaries, parent entities, or external investors.

Go-to-market is multi-channel: direct in-person service delivery at the Chalfont Centre and care homes, plus a distributed digital and community-channel infrastructure (helpline across phone/email/webchat, a comprehensive A–Z website, social media presence on Facebook, X, YouTube, Instagram and LinkedIn, monthly e-newsletters, and events-based fundraising). The organisation markets itself as the only UK charity integrating research, advocacy, and care under a single brand, and operates Cyber Essentials and Cyber Essentials Plus certifications alongside its charity registration.

Short descriptiontext

Epilepsy Society is a UK registered charity (No. 206186) that delivers specialist epilepsy medical services, research including a national genomics programme, residential and supported living care, advocacy, and a national helpline to people with epilepsy, their families, and healthcare professionals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersChalfont Saint Peter, United Kingdom
HQ citystring
Chalfont Saint Peter
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
epilepsy medical services, epilepsy research charity, epilepsy care services, genomics epilepsy research, epilepsy helpline support
Industry2 codes
PRIMARYHLAKAIAB
Epilepsy & Seizure Disorders
SECONDARYHLAKAIAO
Neurogenetics & Rare Neurologic Diseases
NAICS code2 codes
  • Social Assistance624
  • Residential Intellectual and Developmental Disability Facilities62321
SIC code2 codes
  • Services-Health Services8000
  • Services-Skilled Nursing Care Facilities8051
Product category
Epilepsy Healthcare and Research Services
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1STEPS - Supported living
Description

Supported living services for people with epilepsy

epilepsysociety.org.uk
+2 more records
Core offering1 text field

Epilepsy Society is a UK charity that delivers specialist epilepsy medical services (MRI, EEG, Therapeutic Drug Monitoring), world-leading genomics research, residential and supported living care, training programmes, advocacy campaigns, and a confidential helpline to people affected by epilepsy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Up to 70% of people with epilepsy could have their seizures controlled with the right medication
+2 more records
Product overview1 text field

Epilepsy Society operates as a UK charity offering a unified portfolio of services centred on epilepsy care, research, and advocacy. The core offerings include medical diagnostic services (MRI, EEG, Therapeutic Drug Monitoring), research programmes (genomics, neuroimaging, neuropathology), and care services (residential homes, STEPS supported living, respite care). These are complemented by a confidential helpline, epilepsy training programmes for professionals and families, and various advocacy campaigns. The services work together to provide end-to-end support from diagnosis through ongoing care and community support.

Product and service9 records
1Medical Services
CategoryDiagnostic and clinical services
Description

Clinical services delivered at the Chalfont Centre for Epilepsy, including MRI scanning, EEG testing, video telemetry, sleep-deprived and ambulatory EEG, day case admissions, and specialist outpatient appointments for people with epilepsy.

2Therapeutic Drug Monitoring (TDM)
CategoryDiagnostic service
Description

Clinical chemistry service measuring anti-seizure medication levels in patients through blood or saliva samples to optimise epilepsy treatment.

3Research Services
CategoryResearch services
Description

Research programme encompassing genomics, neuroimaging, neuropathology, and neuropsychology to understand and treat epilepsy.

4Genomics Research Programme
CategoryResearch services
Description

World-leading genomics research to understand the genetic architecture of each individual's epilepsy, enabling personalised treatment approaches through whole genome sequencing.

5Care Services
CategoryCare services
Description

Range of care options including residential care homes, STEPS supported living, and overnight respite care tailored to individual needs of people with epilepsy.

6STEPS Supported Living
CategoryCare services
Description

Supported living services for people with epilepsy to maximise independence and life potential.

7Epilepsy Helpline
CategorySupport service
Description

Confidential helpline providing emotional support and information for anyone affected by epilepsy, available by phone, email, or webchat.

8Epilepsy Training
CategoryEducation and training service
Description

Training programmes including family and friends courses and professional training for those working with people affected by epilepsy.

9Advocacy Campaigns
CategoryAdvocacy service
Description

Advocacy campaigns including FixIt4Free for free dental care, #ZachsLaw for online safety, Safe Mum Safe Baby, and medication shortage advocacy to push epilepsy up the political agenda.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major US-based epilepsy charity offering research funding, advocacy, and patient services. Comparable integrated model of research, advocacy, and direct services to people with epilepsy, albeit at much larger scale.

TypeDirect peer
Description

UK charity providing information, support, and advocacy for people with epilepsy. Operates a helpline and campaigns similar to Epilepsy Society, making it the closest direct peer in the UK epilepsy charity space.

TypeDirect peer
Description

Major UK charity combining research funding, information and support services, and advocacy for a single neurological condition. Highly comparable charity operating model and structure to Epilepsy Society.

TypeBroad incumbent
Description

Large UK health charity combining research funding, patient information, and retail-based fundraising. Comparable charity operating model at much larger scale; useful benchmark for charity growth and fundraising infrastructure.

TypeBroad incumbent
Description

Major UK charity combining research, support services, and advocacy for people affected by a specific condition. Highly comparable integrated charity model with helpline, information, and campaigning functions.

TypeBroad incumbent
Description

Global professional organisation driving epilepsy research, education, and clinical guidelines. Comparable in research focus and influence on epilepsy care standards, though operates internationally rather than as a UK service provider.

TypeDirect peer
Description

UK charity dedicated to funding and driving epilepsy research. Closely comparable research mission and overlapping donor base with Epilepsy Society's research programme.

TypeDirect peer
Description

UK charity focused on Sudden Unexpected Death in Epilepsy, combining research funding, awareness, and bereavement support. Operates in the same UK epilepsy charity ecosystem with overlapping constituencies.

TypeDirect peer
Description

UK charity funding research and providing information on a neurological condition, with comparable research-driven mission and fundraising model. Similar size and operational profile to Epilepsy Society within the neurological charity space.

TypeDirect peer
Description

UK charity focused on children and young people with epilepsy, combining specialist residential education, medical services, and research. Comparable model of combining care, research, and support services in the epilepsy space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Epilepsy Society

Epilepsy Healthcare and Research Servicesepilepsysociety.org.uk

Epilepsy Society is a UK registered charity (No. 206186) that delivers specialist epilepsy medical services, research including a national genomics programme, residential and supported living care, advocacy, and a national helpline to people with epilepsy, their families, and healthcare professionals.

What Epilepsy Society does

Epilepsy Society is a UK registered charity (Charity No. 206186) founded in 1892 and headquartered at the Chalfont Centre in Chalfont St Peter, Buckinghamshire, with a workforce of 251–500 staff. It operates across four functional pillars: specialist medical services (MRI scanning, EEG recording including video telemetry, sleep-deprived EEG, ambulatory EEG, and Therapeutic Drug Monitoring), a research programme spanning genomics, neuroimaging, neuropathology, and neuropsychology — including the UK's only specialist epilepsy genomics clinic running whole genome sequencing — care services (residential care homes, STEPS supported living, overnight respite), and an advocacy and information function delivered via a confidential helpline, training programmes for families and professionals, and a global-facing website (epilepsysociety.org.uk). The proprietary EASEE device (Epicranial Application of Stimulation Electrodes for Epilepsy) is offered on the NHS for people with drug-resistant focal seizures.

The organisation funds its operations through a diversified income mix including individual donations, legacies and gifts in Wills, membership fees, fundraising events (walks, treks, runs, skydiving, overseas challenges), corporate partnerships, and shop proceeds; services are delivered free at the point of use consistent with its charitable mission. It serves a UK population of more than 600,000 people with epilepsy and addresses a clinical burden of 79 new diagnoses per day and roughly 1,200 epilepsy-related deaths per year. Customer-facing segments include people with epilepsy (and subgroups such as children, women, and those with learning disabilities), families and carers, healthcare professionals, and people requiring residential or supported living care. The organisation is governed by a Board of Trustees with Clare Pelham as Chief Executive, and there are no subsidiaries, parent entities, or external investors.

Go-to-market is multi-channel: direct in-person service delivery at the Chalfont Centre and care homes, plus a distributed digital and community-channel infrastructure (helpline across phone/email/webchat, a comprehensive A–Z website, social media presence on Facebook, X, YouTube, Instagram and LinkedIn, monthly e-newsletters, and events-based fundraising). The organisation markets itself as the only UK charity integrating research, advocacy, and care under a single brand, and operates Cyber Essentials and Cyber Essentials Plus certifications alongside its charity registration.

Epilepsy Society firmographics

Firmographics
Name
Epilepsy Society
Legal name
Epilepsy Society
Website
https://epilepsysociety.org.uk
Company type
Private
Founded year
1892
Operating status
Operating
Headcount range
101–250 employees
Short description
Epilepsy Society is a UK registered charity (No. 206186) that delivers specialist epilepsy medical services, research including a national genomics programme, residential and supported living care, advocacy, and a national helpline to people with epilepsy, their families, and healthcare professionals.
Ownership category
akta.pro rank

Epilepsy Society industry classification

Industry
Product category
Epilepsy Healthcare and Research Services
NAICS
Social Assistance (624), Residential Intellectual and Developmental Disability Facilities (62321)
SIC
Services-Health Services (8000), Services-Skilled Nursing Care Facilities (8051)
akta.pro industry
PRIMARYHLAKAIAB
Epilepsy & Seizure Disorders
SECONDARYHLAKAIAO
Neurogenetics & Rare Neurologic Diseases

Keywords

  • Epilepsy medical services
  • Epilepsy research charity
  • Epilepsy care services
  • Genomics epilepsy research
  • Epilepsy helpline support

Where Epilepsy Society is headquartered

Location

Headquarters

HQ city
Chalfont Saint Peter
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Epilepsy Society business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Distribution channels6 records

Marketing channels8 records

Epilepsy Society product offering

Product offering

Core offering

Epilepsy Society is a UK charity that delivers specialist epilepsy medical services (MRI, EEG, Therapeutic Drug Monitoring), world-leading genomics research, residential and supported living care, training programmes, advocacy campaigns, and a confidential helpline to people affected by epilepsy.

Product overview

Epilepsy Society operates as a UK charity offering a unified portfolio of services centred on epilepsy care, research, and advocacy. The core offerings include medical diagnostic services (MRI, EEG, Therapeutic Drug Monitoring), research programmes (genomics, neuroimaging, neuropathology), and care services (residential homes, STEPS supported living, respite care). These are complemented by a confidential helpline, epilepsy training programmes for professionals and families, and various advocacy campaigns. The services work together to provide end-to-end support from diagnosis through ongoing care and community support.

Differentiator

Problem solved

Functional benefit

Brands

  • STEPS - Supported living: Supported living services for people with epilepsy
  • The Phoenix Cafe
  • Genomics Research Programme

Products and services

  • Medical Services Clinical services delivered at the Chalfont Centre for Epilepsy, including MRI scanning, EEG testing, video telemetry, sleep-deprived and ambulatory EEG, day case admissions, and specialist outpatient appointments for people with epilepsy.
  • Therapeutic Drug Monitoring (TDM) Clinical chemistry service measuring anti-seizure medication levels in patients through blood or saliva samples to optimise epilepsy treatment.
  • Research Services Research programme encompassing genomics, neuroimaging, neuropathology, and neuropsychology to understand and treat epilepsy.
  • Genomics Research Programme World-leading genomics research to understand the genetic architecture of each individual's epilepsy, enabling personalised treatment approaches through whole genome sequencing.
  • Care Services Range of care options including residential care homes, STEPS supported living, and overnight respite care tailored to individual needs of people with epilepsy.
  • STEPS Supported Living Supported living services for people with epilepsy to maximise independence and life potential.
  • Epilepsy Helpline Confidential helpline providing emotional support and information for anyone affected by epilepsy, available by phone, email, or webchat.
  • Epilepsy Training Training programmes including family and friends courses and professional training for those working with people affected by epilepsy.
  • Advocacy Campaigns Advocacy campaigns including FixIt4Free for free dental care, #ZachsLaw for online safety, Safe Mum Safe Baby, and medication shortage advocacy to push epilepsy up the political agenda.

Quantifiable outcome

  • Up to 70% of people with epilepsy could have their seizures controlled with the right medication
  • +2 more outcomes

Companies that use Epilepsy Society

Customer profile

Segments6 records

Ideal customer profiles4 records

Epilepsy Society technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Epilepsy Society partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Epilepsy Society competitors and assessment

Company assessment

Direct peers

  • Epilepsy Foundation: Major US-based epilepsy charity offering research funding, advocacy, and patient services. Comparable integrated model of research, advocacy, and direct services to people with epilepsy, albeit at much larger scale.
  • Epilepsy Action: UK charity providing information, support, and advocacy for people with epilepsy. Operates a helpline and campaigns similar to Epilepsy Society, making it the closest direct peer in the UK epilepsy charity space.
  • Parkinson's UK: Major UK charity combining research funding, information and support services, and advocacy for a single neurological condition. Highly comparable charity operating model and structure to Epilepsy Society.
  • Epilepsy Research UK: UK charity dedicated to funding and driving epilepsy research. Closely comparable research mission and overlapping donor base with Epilepsy Society's research programme.
  • SUDEP Action: UK charity focused on Sudden Unexpected Death in Epilepsy, combining research funding, awareness, and bereavement support. Operates in the same UK epilepsy charity ecosystem with overlapping constituencies.
  • Alzheimer's Research UK: UK charity funding research and providing information on a neurological condition, with comparable research-driven mission and fundraising model. Similar size and operational profile to Epilepsy Society within the neurological charity space.
  • Young Epilepsy: UK charity focused on children and young people with epilepsy, combining specialist residential education, medical services, and research. Comparable model of combining care, research, and support services in the epilepsy space.

Broad incumbents

  • British Heart Foundation: Large UK health charity combining research funding, patient information, and retail-based fundraising. Comparable charity operating model at much larger scale; useful benchmark for charity growth and fundraising infrastructure.
  • Macmillan Cancer Support: Major UK charity combining research, support services, and advocacy for people affected by a specific condition. Highly comparable integrated charity model with helpline, information, and campaigning functions.
  • International League Against Epilepsy (ILAE): Global professional organisation driving epilepsy research, education, and clinical guidelines. Comparable in research focus and influence on epilepsy care standards, though operates internationally rather than as a UK service provider.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Epilepsy Society social profiles

Digital presence

Epilepsy Society compliance and trust

Trust signal

Compliance3 records

Epilepsy Society financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Epilepsy Society leadership team

Management profile

Number of profiles

Profiles1 record

Epilepsy Society funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Epilepsy Society M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Epilepsy Society

What does Epilepsy Society do?

Epilepsy Society is a UK charity that delivers specialist epilepsy medical services (MRI, EEG, Therapeutic Drug Monitoring), world-leading genomics research, residential and supported living care, training programmes, advocacy campaigns, and a confidential helpline to people affected by epilepsy.

Is Epilepsy Society a public or private company?

Epilepsy Society is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Epilepsy Society founded?

Epilepsy Society was founded in 1892. It employs 101 to 250 people.

Where is Epilepsy Society based?

Epilepsy Society is headquartered in Chalfont Saint Peter, United Kingdom, in the Europe region.

Who are Epilepsy Society's main competitors?

Direct peers on record are Epilepsy Foundation, Epilepsy Action, Parkinson's UK, Epilepsy Research UK, SUDEP Action, Alzheimer's Research UK and Young Epilepsy. Broad incumbents are British Heart Foundation, Macmillan Cancer Support and International League Against Epilepsy (ILAE).

Does Epilepsy Society have an API?

No public API is recorded for Epilepsy Society.

What industry is Epilepsy Society in?

Epilepsy Society's product category is Epilepsy Healthcare and Research Services. Its primary akta.pro industry code is HLAKAIAB, Epilepsy & Seizure Disorders, with a secondary code of HLAKAIAO, Neurogenetics & Rare Neurologic Diseases. Its NAICS code is 624 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales